BC Week In Review | May 21, 2012
Company News

Biogen Idec sales and marketing update

Biogen Idec launched Avonex Pen intramuscular autoinjector and Avostartgrip in the U.S. The single-use Avonex Pen, which is approved in the EU and Canada, is used for once-weekly delivery of the biotech's multiple sclerosis drug...
BC Week In Review | Mar 5, 2012
Clinical News

Avonex Pen regulatory update

Biogen Idec said FDA approved its single-use Avonex Pen intramuscular autoinjector for the once-weekly delivery of the biotech's multiple sclerosis (MS) drug Avonex interferon beta-1a . The company said FDA also approved a new dose titration...
BC Week In Review | Jun 13, 2011
Clinical News

Avonex Pen regulatory update

Biogen Idec said the European Commission approved its single-use Avonex Pen intramuscular autoinjector for the once-weekly delivery of multiple sclerosis (MS) drug Avonex interferon beta-1a . The company said it will launch the product in the...
BC Week In Review | Apr 25, 2011
Clinical News

Avonex Pen regulatory update

EMA's CHMP issued a positive opinion recommending approval of Biogen Idec's single-use Avonex Pen intramuscular autoinjector for the once-weekly delivery of multiple sclerosis (MS) drug Avonex interferon beta-1a . The company also said the product was...
Items per page:
1 - 4 of 4